Indian Journal of Animal Research

  • Chief EditorK.M.L. Pathak

  • Print ISSN 0367-6722

  • Online ISSN 0976-0555

  • NAAS Rating 6.50

  • SJR 0.263

  • Impact Factor 0.4 (2024)

Frequency :
Monthly (January, February, March, April, May, June, July, August, September, October, November and December)
Indexing Services :
Science Citation Index Expanded, BIOSIS Preview, ISI Citation Index, Biological Abstracts, Scopus, AGRICOLA, Google Scholar, CrossRef, CAB Abstracting Journals, Chemical Abstracts, Indian Science Abstracts, EBSCO Indexing Services, Index Copernicus
Indian Journal of Animal Research, volume 55 issue 10 (october 2021) : 1240-1245

Antimicrobial Susceptibility and Detection of Genes for Antimicrobial Resistance of Mycoplasma bovis, Staphylococcus aureus and Escherichia coli

A. Aksoy1,*
1Eskil Vocation of High School, Laboratory Veterinary Science, Aksaray University, Turkey.
Cite article:- Aksoy A. (2021). Antimicrobial Susceptibility and Detection of Genes for Antimicrobial Resistance of Mycoplasma bovis, Staphylococcus aureus and Escherichia coli . Indian Journal of Animal Research. 55(10): 1240-1245. doi: 10.18805/IJAR.B-1343.
Background: Mycoplasma bovis (Gram-positive bacteria) belongs the class Mollicutes and to the family Mycoplasmataceae (Maunsell and Donovan, 2009). It is a cell wall-less bacterium and are instead enveloped by a complex plasma membrane. In cattle, M. bovis is widely known causes various diseases, such respiratory disease, mastitis, arthritis and otitis.

Methods: The present study was aimed to determine the antimicrobial susceptibility and identify the genes for antimicrobial resistance of Mycoplasma bovis PG45, Staphylococcus aureus and Escherichia coli. M. bovis PG45, S. aureus and E.coli were subjected to test for their sensitivity to various clinically important antibiotics (Cefotaxime, Cefuroxime, Cefaclor Cefalexin, Ofloxacin, Norfloxacin, Nalidixic acid, Amikacin, Ampicillin, Oxacilin, Amoxyclav, Rifampicin, Penicillin G and Tylosin). The minimal inhibitory concentration (MIC) of each antimicrobial agent was determined by applying an agar dilution method. Polymerase Chain reaction (PCR) was used to amplify specific DNA fragments and thus to determine the presence or absence of a target gene (VspA, tet k and tetA). 

Result: Showed the MIC values and the presence of VspA, tetK and tetA in M. bovis PG45, S. aureus and E. coli respectively.
Mycoplasma bovis (Gram-positive bacteria) belongs the class Mollicutes and to the family Mycoplasmataceae (Maunsell and Donovan, 2009). It is a cell wall-less bacterium and are instead enveloped by a complex plasma membrane (Lysnyansky and Ayling, 2016; Maunsell and Donovan, 2009). Mycoplasmas are the smallest microorganisms capable of self-replication (diameter of approximately 0.2 to 0.3 μm) with the (smallest genomes 500 to 1,000 genes)  (Gautier Bouchardon, 2018).
         
The mycoplasma cell contains the minimum set of organelles important for growth and replication: a plasma membrane, ribosomes and a genome consisting of a double-stranded circular DNA molecule (Lysnyansky and Ayling, 2016). In cattle, M. bovis is widely known causes various diseases, such respiratory disease, mastitis, arthritis and otitis (Malmberg et al., 2020; Bhaladhare et al., 2018). 
         
It is now known that this mycoplasma species is the most important etiological agent of bovine respiratory disease and often it is the only causing agent implicated in the chronic forms of respiratory disease for bovine (Goswami et al., 2019; Caswell et al., 2010).
         
In cattle, control of M. bovis infections is inherently difficult. The resulting clinical signs and disease are increasingly recognized as having a significant adverse impact on animal welfare and the economy of cattle farming around the world (Dudek et al., 2020; Barua et al., 2017). Chronic infections of M. bovis are responsible for economic losses in cattle and milk production. The only approaches that can be used in attempts to control M. bovis infections are healthy control measures and antimicrobial treatment. However, M. bovis is resistant to b-lactams and to all antimicrobials that target the cell wall (cell-wall-less bacterium). In addition, mycoplasmas are also naturally resistant to polymyxins, sulfonamides, trimethoprim, nalidixic acid and rifampin (Lysnyansky and Ayling, 2016).
         
There is worldwide concern about the appearance and rise of bacterial resistance to commonly used antibiotics (Aslam et al., 2018). 16S rDNA genes are coding for the small ribosomal subunit have great important in the phylogenetic analysis of bacteria because of their universal distribution and because mutations occur at a slow and constant rate (Alsanie et al., 2018).
         
M. bovis has an elaborate genetic system encoding (Vsps) that consider an antigenic repertoire for this pathogen each (Vsp) was shown to possess the following features: (i) independent high-frequency phase variation between ONand OFF expression states, (ii) membrane anchorage via the N-terminal domain, (iii) independent high-frequency size variation and a C-terminal region which is surface exposed, (iv) extensive repetitive domains over the full length of the Vsp molecule, and (v) regions of shared epitopes (Bürki et al., 2015; Nussbaum et al., 2002; Lysnyansky et al., 1999).
         
Tetracyclines are considered broad spectrum antibiotics used against Gram-positive and Gram-negative. Tetracyclines inhibit protein synthesis through bacterial ribosome from associating with the aminoacyl-tRNA (Ullah et al., 2012). TetK, tetM, tetO and tetL genes related with Tetacycline resistance genes which prevent tetracycline from accumulating within the cell in Gram-positive bacteria (Ullah et al., 2012).
         
Comprehensive efforts are needed to reduce the pace of resistance by studying emergent microorganisms, mechanisms of resistance and antimicrobial drugs (Aslam et al., 2018). The present study aimed to identify the molecular mechanisms of resistance in M. bovis, S. aureus and E. coli against antimicrobial drugs by phenotyping and genotyping method.
Microbial culture
 
The study was conducted of 2019-2020 at the research in Eskil Vocation of High School, Laboratory Veterinary Science, Aksaray University, Turkey. Microorganisms which that have been used in this study consisted of Mycoplasma bovis PG45 obtained from ATCC S. aureus and E.coli isolates identified. Inhibitory concentration (MIC) of each antimicrobial agent was determined by applying an agar dilution method with some modifications and in accordance with the recommendations of Hannan (2000) and Kolarević et al., (2016).
         
Twenty antimicrobial agents (Table 1) were included in the testing which listed in Table 1. Based on Hannan (2000) using 104 -105 CCU/ml of each strain. In brief, the 96-wells microtiter plates were designed to contain Mycoplasma broth medium. Antimicrobial agent concentrations ranged from 0.39 to 100 μg/ml for all antibiotics. The procedures were performed as described by Hannan (2000). All antimicrobial agents were dissolved in the optimum diluent at 100 µg/ml. The MIC value of each isolate was defined as the lowest concentration of the antibiotic that completely inhibits the growth in the broth after a one week incubation period. MIC50 and MIC90 values were defined as the lowest concentrations that inhibit 50% and 90% of bacterial tested.
 

Table 1: List of antibiotic potency.


 
DNA extraction and primers design
 
DNA was extracted from identified M. bovis PG45, E. coli and S. aureus cultures using DNA minikit (QIAGEN QIAmp DNA mini kit, Germany). Primer set A was designed on the basis of 16S rRNA nucleotide sequences, as an effective tool for amplification of mycoplasma DNA. Set B specifically targets a variable initial portion of the vspA gene of M. bovis PG45T annealing to its more conserved flanking regions and was used for molecular characterization. S. aureus strain was tested for the presence of following antibiotic resistant gene Tetracycline (tetK), E. coli strain was tested for the presence of following antibiotic resistant gene Tetracycline (tetA). Amplifications were performed in a programmable thermal cycler:
1. For the Set A (16SrRNA) encoding gene (Kojima et al., 1997), 94°C (7.5min) of initial denaturation and then 30 cycles of denaturation at 94°C (30s), annealing at 56°C (30s), elongation at 72°C (60s) and final extension in 72°C (5min).
         
For Set B (VspA) an initial denaturation step (94°C for 5 min), followed by 35 cycles of denaturation (94°C for 1 min), annealing (55°C for 1 min) and extension (72°C for 1.5 min). A final extension step at 72°C for 10 min was included.
2. For tetK gene in S. aureus an initial denaturation step (94°C for 5 min), followed by 35 cycles of denaturation (94°C for 1 min), annealing (57°C for 1 min) and extension (72°C for 1.5 min). A final extension step at 72°C for 10 min was included.
3. For tet (A) gene in E. coli an initial denaturation step (94°C for 5 min), followed by 30 cycles of denaturation (94°C for 20 sec), annealing (55°C for 1 min 15 sec) and extension (72°C for 15 sec). A final extension step at 72°C for 2 min was included.
         
All the PCR amplicons were visualized using an ultraviolet light box after electrophoresis on a 1.5% agarose gel containing 0.5 µg/ml ethidium bromide.
Evaluation of antibiotics activity
 
The results of antibacterial susceptibility testing are presented in (Table 2) for all the bacterial pathogens, M. bovis, S. aureus and E. coli. M. bovis, S. aureus and E. coli showed higher resistance to most tested antibiotics (Cefotaxime, Cefuroxime, Cefaclor Cefalexin, Ofloxacin, Norfloxacin, Nalidixic acid, Amikacin, Ampicillin, Oxacilin, Amoxyclav, Rifampicin, Penicillin G and Tylosin) with MIC50<100 MIC90<100.
 

Table 2: Target, specificity and source of the primer sets used for PCR amplifications.


         
In Table 3. M. bovis showed only sensitive to Enrofloxacin with MIC50 0.39 and MIC90 1.56, but S. aureus and E. coli showed higher resistance with MIC50 100 and MIC90>100. M. bovis showed resistance to Gentamicin with MIC50>25 MIC90>50, but S. aureus and E. coli showed higher resistance with MIC50>100 and MIC90>100.
 

Table 3: Minimum inhibitory concentration (MIC) values of M. bovis, S. aureus and E. coli.


 
PCR results showed that all tested bacteria (M. bovis, S. aureus and E. coli) were positive for 16SrRNA gene as shown in (Fig 1). M. bovis was positive for VspA gene but negative for tetA and tetK genes (Fig 2). E. coli was positive for tetA gene but negative for VspA and tetK genes (Fig 3), but S. aureus was positive for but negative for VspA and tetA genes (Fig 4). The spread of bacterial infection is a major concern worldwide because infections caused by these pathogens may lead to prolonged hospital stays, higher medical costs and increase rates of morbidity and mortality (Cho et al., 2019).
 

Fig 1: PCR results of the amplification of the 16SrRNA gene.


 

Fig 2: PCR results of the amplification of the VspA gene.


 

Fig 3: PCR results of the amplification of the tetA gene.


 

Fig 4: PCR results of the amplification of the tetK gene.


         
Sequencing analysis of 16SrRNA gene fragments has proved to be one of the most significant tools for phylogenetic studies and for many diagnostic applications (Sahar et al., 2013). Many studies have proved that the evolution of antibiotic resistance is due to gene mutations (Szacawa et al., 2014). A number of recent studies indicate that the efficacy of tetracyclines, lincosamides and macrolides against M. bovis has diminished. So it is needful to search for alternative compounds that could effectively inhibit these bacteria (Szacawa et al., 2014).
         
In this study M. bovis, showed highly resistance to most of antibiotics and positive for VspA gene. The possible explanation for this Mycoplasma possesses a complex system capable of creating large repertoires of cell surface phenotypes which may impact the various interactions of this organism with its host and dictate its potential as a successful infectious agent and pathogen (Droesse et al., 1995).
         
In this study M. bovis, showed highly resistance to tetracycline MIC50 was 100, MIC90 was 100. Similar results were obtained by (Siugzdaite et al., 2012) that proved the MICs for oxytetracycline of all isolates of M. bovis were higher than the breakpoint (4-16 µg/ml). In veterinary medicine, raises in tetracycline resistance have been described for M. bovis, M. hyopneumoniae, M. bovirhinis and M. alkalescens (Thomas et al., 2003).
         
Resistant Mycoplasmas exhibit a reduced uptake of tetracycline into cells, lowering the initial concentration, and have acquired the ability to excrete the drug out of the cell (Siugzdaite et al., 2012; Boothe 1998). The frequent use of oxytetracycline for the treatment of respiratory disease infection is a possible explanation for the high prevalence of oxytetracycline resistance in M. bovis. In the present study, all M. bovis isolates were highly resistant to beta-lactam antimicrobials (penicillin G, Ampicillin, Oxacilin, Cefotaxime) and this due to the lack of a cell wall (cell-wall-less bacterium) makes the Mycoplasma resistant to b-lactams and to all antimicrobials that target the cell wall. These results were similar to the findings of (Siugzdaite et al., 2012) that confirmed penicillin G can be used in antimicrobial susceptibility testing only as a negative control against Mycoplasma. S. aureus isolate in this study showed higher resistance to tetracycline with (MIC50<100 MIC90<100) and in genotype results was positive for tetK gene. These results were similar to the findings of (Ullah et al., 2012) that found the majority of the S. aureus strains either carried tetK or tetL genes and highly resistance to tetracycline. The presence of tetK prevents the accumulation of tetracycline within bacterialcells by the synthesis of a cytoplasmic membrane protein which pumps tetracycline out of the cell at a quicker rate than it enters (Ullah et al., 2012).
         
E. coli in this study showed higher resistance to tetracycline with (MIC50<100 MIC90<100) and in genotype results was positive for tetA gene. These results were similar to the findings of (Ullah et al., 2012) that found E. coli strains were phenotypically resistant to tetracycline and showed all tetracycline-resistant strains carried at least one of the tetA, tetB and tetc genes. In conclusion, our results demonstrated the presence of Vsps, tetK and tetA in M. bovis, S. aureus and E. coli respectively make this strains multi-drug resistant So it is needful to search for alternative compounds that could effectively inhibit these bacteria. Comprehensive efforts are needed to minimize the pace of resistance by studying emergent microorganisms, resistance mechanisms and antimicrobial agents.
In conclusion, our results demonstrated the presence of VspA, tetK and tetA in M. bovisS.aureus and E. coli respectively. The tested bacteria also showed resistant to different antimicrobials so it is needful to search for alternative compounds that could effectively inhibit these bacteria. Comprehensive efforts are needed to minimize the pace of resistance by studying more number of emergent microorganisms, and antimicrobial agents.

  1. Alsanie, W.F., Felemban, E.M., Farid, M.A., Hassan, M.M., Sabry, A. and Gaber, A. (2018). Molecular identification and phylogenetic analysis of multidrug-resistant bacteria using 16S rDNA sequencing. Journal of Pure and Applied Microbiology. 12(2): 489-496.þ

  2. Aslam, B., Wang, W., Arshad, M.I., Khurshid, M., Muzammil, S., Rasool, M.H. and Salamat, M.K.F. (2018). Antibiotic resistance: a rundown of a global crisis. Infection and drug resistance. 11: 1645-1658.

  3. Boothe, D. (1998): The Marck Veterinary Manual. In: Antibacterial Agents. [Asiello S (eds.)]. Merck and Co, Inc, Philadelphia. 1745-1788.

  4. Bürki, S., Frey, J. and Pilo, P. (2015). Virulence, persistence and dissemination of Mycoplasma bovis. Veterinary microbiology. 179(1-2): 15-22.

  5. Barua, A.G., Raj, H., Kumar, A., Barua, C.C., Purkayastha, A. and Patowary, P. (2017). Diagnosis of Mycobacterium bovis infection in livestock using gamma interferon assay and single intradermal comparative tuberculin test in Assam and Meghalaya. Indian Journal of Animal Research. 51(4): 737-741.

  6. Bhaladhare, A., Sharma, D., Chauhan, A., Kumar, A., Sonwane, A., Singh, R.V., Kumar, P., Kumar, S., Bhushan, B. (2018). Association study of Single Nucleotide Polymorphisms (SNP) in Toll-like Receptor 9 gene with bovine tuberculosis.Indian Journal of Animal Research. 52(4): 533-537.

  7. Caswell, J.L., Bateman, K. G., Cai, H.Y. and Castillo-Alcala, F. (2010). Mycoplasma bovis in respiratory disease of feedlot cattle. Veterinary Clinics: Food Animal Practice. 26(2): 365-379.

  8. Cho, S., Nguyen, H.A.T., McDonald, J.M., Woodley, T.A., Hiott, L. M., Barrett, J.B., Jackson, C.R., Frye, J.G. (2019). Genetic characterization of antimicrobial-resistant Escherichia coli isolated from a mixed-use watershed in northeast Georgia, USA. International Journal of Environmental Research and Public Health. 16(19): 3761.

  9. Droesse, M., G. Tangen, I. Gummelt, H. Kirchhoff, L.R. Washburn and R. Rosengarten. 1995. Major membrane proteins and lipoproteins as highly variable immunogenic surface components and strain-specific antigenic markers of Mycoplasma arthritidis. Microbiology. 141: 3207-3219.

  10. Dudek, K., Nicholas, R.A., Szacawa, E. and Bednarek, D. (2020). Mycoplasma bovis Infections-Occurrence, Diagnosis and Control. Pathogens. 9(8): 640.

  11. Gautier Bouchardon, A.V. (2018). Antimicrobial resistance in Mycoplasma spp. Antimicrobial Resistance in Bacteria from Livestock and Companion Animals. 425-446.

  12. Goswami, P., Banga, H.S. and Mahajan, V. (2019). Pathological description of naturally occurring Mycoplasma bovis associated pneumonia in bovine calves. Indian Journal of Animal Research. 53(6): 799-806.

  13. Kolarević, S., Milovanović, D., Avdović, M., Oalđe, M., Kostić, J., Sunjog, K., Nikolić1, B., Knežević-Vukčević, J., Vuković-Gačić, B. (2016). Optimisation of the microdilution method for detection of minimum inhibitory concentration values in selected bacteria. Botanica Serbica. 40(1): 29-36.

  14. Lysnyansky, I., Sachse, K., Rosenbusch, R., Levisohn, S. and Yogev, D. (1999). The vsp locus of Mycoplasma bovis: gene organization and structural features. Journal of Bacteriology. 181(18): 5734-5741.

  15. Lysnyansky, I., and Ayling, R.D. (2016). Mycoplasma bovis: mechanisms of resistance and trends in antimicrobial susceptibility. Frontiers in Microbiology. 7: 595.

  16. Maunsell, F.P., and Donovan, G.A. (2009). Mycoplasma bovis infections in young calves. Veterinary Clinics of North America: Food Animal Practice. 25(1): 139-177.

  17. Malmberg, J. L., O’Toole, D., Creekmore, T., Peckham, E., Killion, H., Vance, M., Ashley, R., Johnson, M., Anderson, C., Vasquez, M.,Sandidge, D., Mildenberger, J., Hull, N., Bradway, D., Cornish, T., Register K.B., Sandidge, D. (2020). Mycoplasma bovis Infections in Free-Ranging Pronghorn, Wyoming, USA. Emerging infectious diseases. 26(12): 2807. 

  18. Ninet, B., Monod, M., Emler, S., Pawlowski, J., Metral, C., Rohner, P., Auckenthaler, R., Hirschel, B. (1996). Two different 16S rRNA genes in a mycobacterial strain. Journal of Clinical Microbiology. 34(10): 2531-2536.

  19. Siugzdaite, J., Gabinaitiene, A. and Kerziene, S. (2012). Susceptibility of Mycoplasma bovis field isolates to antimicrobial agents. Veterinarni Medicina. 57(11):

  20. Szacawa E., Horecka A., Bednarek D., Niemczuk K. (2014). Antibiotic resistance and the mechanisms of its development in the case of Mycoplasma bovis infection in cattle. Medycyna Weterynaryjna, 70(07).

  21. Sahar, E.O., Metwally, A.M., Al-Saud, N.B.S. and Ibrahim, M.M.M. (2013). Molecular typing of different isolates of Mycoplasma bovis. In Proceedings of the 6th Scientific Conference of Animal Wealth Research in the Middle East and North Africa, Hurghada, Egypt, 27-30 September 2013 (pp. 277-290). Massive Conferences and Trade Fairs.

  22. Sun, P., Luo, H., Zhang, X., Xu, J., Guo, Y. and He, S. (2018). Whole-genome sequence of Mycoplasma bovis strain Ningxia-1. Genome Announcements. 6: e01367-17.

  23. Ullah, F., Malik, S.A., Ahmed, J., Shah, S.M., Ayaz, M., Hussain, S. and Khatoon, L. (2012). Investigation of the genetic basis of tetracycline resistance in Staphylococcus aureus from Pakistan. Tropical Journal of Pharmaceutical Research. 11(6): 925-931

Editorial Board

View all (0)